Phospho-Akt Immunoreactivity in Prostate Cancer: Relationship to Disease Severity and Outcome, Ki67 and Phosphorylated EGFR Expression

International Variation in Prostate Cancer Incidence and Mortality Rates

(2012) Melissa M. Center et al.   EUROPEAN UROLOGY

Pathobiological Implications of the Expression of EGFR, pAkt, NF-κB and MIC-1 in Prostate Cancer Stem Cells and Their Progenies

(2012) Murielle Mimeault et al.   PLoS One

Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance

(2012) Andreas Josefsson et al.   SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY

Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial

(2011) Eva Johansson et al.   LANCET ONCOLOGY

Unknown

(2011) Murielle Mimeault et al.   MOLECULAR MEDICINE

Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?

(2011) Jones T. Nauseef et al.   Nature Reviews Urology

Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-κB signalling pathway and prognostic significance in prostate cancer

(2010) I H Koumakpayi et al.   BRITISH JOURNAL OF CANCER

Low Levels of Phosphorylated Epidermal Growth Factor Receptor in Nonmalignant and Malignant Prostate Tissue Predict Favorable Outcome in Prostate Cancer Patients

(2010) P. Hammarsten et al.   CLINICAL CANCER RESEARCH

Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells

(2010) Y Gan et al.   ONCOGENE

EGFR Signaling and Drug Discovery

(2010) Georg Lurje et al.   ONCOLOGY

Stromal PDGFRβ Expression in Prostate Tumors and Non-Malignant Prostate Tissue Predicts Prostate Cancer Survival

(2010) Christina Hägglöf et al.   PLoS One

Tumour Cannabinoid CB1 Receptor and Phosphorylated Epidermal Growth Factor Receptor Expression Are Additive Prognostic Markers for Prostate Cancer

(2010) Christopher J. Fowler et al.   PLoS One

Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients

(2008) P McCall et al.   BRITISH JOURNAL OF CANCER